eHIV Review
Newer NNRTI Agents in Clinical Practice
July 11, 2023
Non-nucleoside reverse transcriptase inhibitors (NNRTIs). Rilpivirine, in combination with cabotegravir, provides a long-acting injectable option for both treatment and PrEP. But what risk factors have been associated with virologic failure? Doravirine ap
New York
EHIV Review podcast channel
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast